These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15777080)

  • 21. Development of a toxicogenomics in vitro assay for the efficient characterization of compounds.
    Yang Y; Abel SJ; Ciurlionis R; Waring JF
    Pharmacogenomics; 2006 Mar; 7(2):177-86. PubMed ID: 16515397
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing next-generation sequencing and microarray technologies in a toxicological study of the effects of aristolochic acid on rat kidneys.
    Su Z; Li Z; Chen T; Li QZ; Fang H; Ding D; Ge W; Ning B; Hong H; Perkins RG; Tong W; Shi L
    Chem Res Toxicol; 2011 Sep; 24(9):1486-93. PubMed ID: 21834575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
    Merrick BA; Bruno ME
    Curr Opin Mol Ther; 2004 Dec; 6(6):600-7. PubMed ID: 15663324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of microarray-based analysis of gene expression in the field of toxicogenomics.
    Mei N; Fuscoe JC; Lobenhofer EK; Guo L
    Methods Mol Biol; 2010; 597():227-41. PubMed ID: 20013237
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxicogenomics strategies for predicting drug toxicity.
    Martin R; Rose D; Yu K; Barros S
    Pharmacogenomics; 2006 Oct; 7(7):1003-16. PubMed ID: 17054411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Japanese toxicogenomics project: application of toxicogenomics.
    Uehara T; Ono A; Maruyama T; Kato I; Yamada H; Ohno Y; Urushidani T
    Mol Nutr Food Res; 2010 Feb; 54(2):218-27. PubMed ID: 20041446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The utility of DNA microarrays for characterizing genotoxicity.
    Newton RK; Aardema M; Aubrecht J
    Environ Health Perspect; 2004 Mar; 112(4):420-2. PubMed ID: 15033590
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicogenomics in drug discovery and development: mechanistic analysis of compound/class-dependent effects using the DrugMatrix database.
    Ganter B; Snyder RD; Halbert DN; Lee MD
    Pharmacogenomics; 2006 Oct; 7(7):1025-44. PubMed ID: 17054413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toxicogenomics in drug development: a match made in heaven?
    Qin C; Tanis KQ; Podtelezhnikov AA; Glaab WE; Sistare FD; DeGeorge JJ
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):847-9. PubMed ID: 27050123
    [No Abstract]   [Full Text] [Related]  

  • 30. The importance of applying toxicogenomics to increase the efficiency of drug discovery.
    Barros SA
    Pharmacogenomics; 2005 Sep; 6(6):547-50. PubMed ID: 16142994
    [No Abstract]   [Full Text] [Related]  

  • 31. Toxicogenomics in the pharmaceutical industry: hollow promises or real benefit?
    Lühe A; Suter L; Ruepp S; Singer T; Weiser T; Albertini S
    Mutat Res; 2005 Aug; 575(1-2):102-15. PubMed ID: 15924886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In pursuit of effective toxicogenomics.
    Gant TW; Zhang SD
    Mutat Res; 2005 Aug; 575(1-2):4-16. PubMed ID: 15885710
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practical application of toxicogenomics for profiling toxicant-induced biological perturbations.
    Kiyosawa N; Manabe S; Yamoto T; Sanbuissho A
    Int J Mol Sci; 2010 Sep; 11(9):3397-412. PubMed ID: 20957103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Toxicogenomics Project and drug safety evaluation.].
    Urushidani T
    Nihon Yakurigaku Zasshi; 2010 Jul; 136(1):46-9. PubMed ID: 20628214
    [No Abstract]   [Full Text] [Related]  

  • 35. Sources of variation in baseline gene expression levels from toxicogenomics study control animals across multiple laboratories.
    Boedigheimer MJ; Wolfinger RD; Bass MB; Bushel PR; Chou JW; Cooper M; Corton JC; Fostel J; Hester S; Lee JS; Liu F; Liu J; Qian HR; Quackenbush J; Pettit S; Thompson KL
    BMC Genomics; 2008 Jun; 9():285. PubMed ID: 18549499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA microarrays as a tool in toxicogenomics.
    de Longueville F; Bertholet V; Remacle J
    Comb Chem High Throughput Screen; 2004 May; 7(3):207-11. PubMed ID: 15134526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Advances in "omics" technologies for toxicological research].
    Inadera H; Uchida M; Shimomura A
    Nihon Eiseigaku Zasshi; 2007 Jan; 62(1):18-31. PubMed ID: 17334089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicogenomics and studies of genomic effects of dietary components.
    Thompson K
    World Rev Nutr Diet; 2010; 101():115-122. PubMed ID: 20436258
    [No Abstract]   [Full Text] [Related]  

  • 39. Application of DNA microarray to toxicological research.
    Shioda T
    J Environ Pathol Toxicol Oncol; 2004; 23(1):13-31. PubMed ID: 14994992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimization of an animal test protocol for toxicogenomics studies (ii); a cross-laboratory gene expression analysis.
    Sumida K; Saito K; Oeda K; Otsuka M; Tsujimura K; Miyaura H; Sekijima M; Nakayama K; Kawano Y; Kawakami Y; Asamoto M; Shirai T
    J Toxicol Sci; 2007 Feb; 32(1):33-45. PubMed ID: 17327692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.